Capricor Therapeutics
CAPR
#5203
Rank
$1.62 B
Marketcap
$28.02
Share price
-2.69%
Change (1 day)
170.15%
Change (1 year)

Capricor Therapeutics (CAPR) Fails to deliver data

Key failure to deliver metrics for Capricor Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Capricor Therapeutics (CAPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Capricor Therapeutics (CAPR) - since 2019

Volume in USD (price x number of shares), data since 2019

Capricor Therapeutics (CAPR) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026$5.29 M-96.64%
2025$0.15 B154.62%
2024$61.89 M1584.06%
2023$3.67 M24.67%
2022$2.94 M-49.93%
2021$5.88 M-88.57%
2020$51.49 M573.14%
2019$7.65 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
$67.61 M$0.17 B๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$2.88 M$15.31 M๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
$20.52 M$47.91 M๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
$2.4 M$11.29 M๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
$0.31 M$1.18 M๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
N/A$0.02 M๐Ÿ‡บ๐Ÿ‡ธ USA